Life Science Leader published an article by EVQLV’s CEO, Andrew Satz, on how AI can be used in pharma to automate, analyze, or accelerate tasks as well as how to leverage AI to assist and augment team members. Written for leaders in the biotech and pharmaceutical industry, the article details strategies and tactics on ways to think about and use AI to transform an organization, its members, and its outcomes. You can find the article here.
“Examining AI as automated, assistive, analytical, accelerated, or augmented intelligence is a framework for thinking about how to apply these tools to data in ways that are aligned with an organization’s goals. This framework is designed to allow those who do not routinely build or employ AI to avoid the overhyped rhetoric of AI and consider the practical outcomes of employing it.”
You can find the article here.